RNase L activation in the cytoplasm induces aberrant processing of mRNAs in the nucleus

• Published in: PLoS pathogens Vol. 18; no. 11; p. e1010930
• Main Authors: Burke, James M, Ripin, Nina, Ferretti, Max B, St Clair, Laura A, Worden-Sapper, Emma R, Salgado, Fernando, Sawyer, Sara L, Perera, Rushika, Lynch, Kristen W, Parker, Roy
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01-11-2022; Public Library of Science (PLoS)
• Subjects: Animals; Biology and life sciences; Cell nuclei; Complications and side effects; COVID-19 - genetics; Cytoplasm; Cytoplasm - metabolism; Development and progression; Endoribonucleases - genetics; Endoribonucleases - metabolism; Gene expression; Genetic aspects; Humans; Mammals; Research and Analysis Methods; Ribonuclease; RNA processing; RNA, Messenger - genetics; RNA, Messenger - metabolism; SARS-CoV-2; Virus diseases; Virus research; United States
• ISSN: 1553-7374; 1553-7366; 1553-7374
• DOI: 10.1371/journal.ppat.1010930

The antiviral endoribonuclease, RNase L, is activated by the mammalian innate immune response to destroy host and viral RNA to ultimately reduce viral gene expression. Herein, we show that RNase L and RNase L-mediated mRNA decay are primarily localized to the cytoplasm. Consequently, RNA-binding proteins (RBPs) translocate from the cytoplasm to the nucleus upon RNase L activation due to the presence of intact nuclear RNA. The re-localization of RBPs to the nucleus coincides with global alterations to RNA processing in the nucleus. While affecting many host mRNAs, these alterations are pronounced in mRNAs encoding type I and type III interferons and correlate with their retention in the nucleus and reduction in interferon protein production. Similar RNA processing defects also occur during infection with either dengue virus or SARS-CoV-2 when RNase L is activated. These findings reveal that the distribution of RBPs between the nucleus and cytosol is dictated by the availability of RNA in each compartment. Thus, viral infections that trigger RNase L-mediated cytoplasmic RNA in the cytoplasm also alter RNA processing in the nucleus, resulting in an ingenious multi-step immune block to protein biogenesis.